Time of ventilator support, time in the ICU and total hospital time with regard to type of transplant and diagnosis
| Indications . | Ventilator time (days) . | P-value . | ICU time (days) . | P-value . | Hospital time (days) . | P-value . |
|---|---|---|---|---|---|---|
| LTx type | 0.001 | <0.001 | 0.386 | |||
| SLTx | 1.0 (0.04–62) | 4 (0.5–81) | 42 (12–134) | |||
| DLTx | 2.0 (0.06–95) | 7.6 (1–105) | 42 (12–176) | |||
| HLTx | 7.0 (1.00–22) | 57.3 (24–91) | 67 (33–98) | |||
| Diagnosis | 0.007 | 0.001 | 0.645 | |||
| COPD | 1.0 (0.04–95) | 5.2 (0.5–95) | 44 (12–164) | |||
| AAT1 | 1.1 (0.22–62) | 4 (1–66) | 43 (12–176) | |||
| CF | 1.9 (0.06–30) | 7.7 (1–75) | 41 (12–122) | |||
| PF | 2.6 (0.44–62) | 8 (2–81) | 46 (20–127) | |||
| SPH, EIS | 10.5 (1.00–65) | 36 (4–69) | 47 (33–87) | |||
| PPH | 4.5 (0.69–80) | 12.5 (1–105) | 47 (23–147) | |||
| Sarcoidosis | 5.8 (0.40–37) | 19.4 (2–73) | 58 (32–120) | |||
| GVHD | 6.3 (1.00–15) | 11.6 (4–22) | 38 (30–79) | |||
| Bronchiectasis | 2.0 (1.31–9) | 5.8 (3–35) | 41 (31–64) | |||
| Total | 2.0 (0.04–9) | 6.6 (0.5–105) | 43 (12–176) |
| Indications . | Ventilator time (days) . | P-value . | ICU time (days) . | P-value . | Hospital time (days) . | P-value . |
|---|---|---|---|---|---|---|
| LTx type | 0.001 | <0.001 | 0.386 | |||
| SLTx | 1.0 (0.04–62) | 4 (0.5–81) | 42 (12–134) | |||
| DLTx | 2.0 (0.06–95) | 7.6 (1–105) | 42 (12–176) | |||
| HLTx | 7.0 (1.00–22) | 57.3 (24–91) | 67 (33–98) | |||
| Diagnosis | 0.007 | 0.001 | 0.645 | |||
| COPD | 1.0 (0.04–95) | 5.2 (0.5–95) | 44 (12–164) | |||
| AAT1 | 1.1 (0.22–62) | 4 (1–66) | 43 (12–176) | |||
| CF | 1.9 (0.06–30) | 7.7 (1–75) | 41 (12–122) | |||
| PF | 2.6 (0.44–62) | 8 (2–81) | 46 (20–127) | |||
| SPH, EIS | 10.5 (1.00–65) | 36 (4–69) | 47 (33–87) | |||
| PPH | 4.5 (0.69–80) | 12.5 (1–105) | 47 (23–147) | |||
| Sarcoidosis | 5.8 (0.40–37) | 19.4 (2–73) | 58 (32–120) | |||
| GVHD | 6.3 (1.00–15) | 11.6 (4–22) | 38 (30–79) | |||
| Bronchiectasis | 2.0 (1.31–9) | 5.8 (3–35) | 41 (31–64) | |||
| Total | 2.0 (0.04–9) | 6.6 (0.5–105) | 43 (12–176) |
ICU: intensive care unit; COPD: chronic obstructive pulmonary disease; AAT1: α1-antitrypsin deficiency; CF: cystic fibrosis; PF: pulmonary fibrosis; SPH: secondary pulmonary hypertension; EIS: Eisenmenger’s syndrome; PPH: primary pulmonary hypertension; GVHD: graft-vs-host disease.
Time of ventilator support, time in the ICU and total hospital time with regard to type of transplant and diagnosis
| Indications . | Ventilator time (days) . | P-value . | ICU time (days) . | P-value . | Hospital time (days) . | P-value . |
|---|---|---|---|---|---|---|
| LTx type | 0.001 | <0.001 | 0.386 | |||
| SLTx | 1.0 (0.04–62) | 4 (0.5–81) | 42 (12–134) | |||
| DLTx | 2.0 (0.06–95) | 7.6 (1–105) | 42 (12–176) | |||
| HLTx | 7.0 (1.00–22) | 57.3 (24–91) | 67 (33–98) | |||
| Diagnosis | 0.007 | 0.001 | 0.645 | |||
| COPD | 1.0 (0.04–95) | 5.2 (0.5–95) | 44 (12–164) | |||
| AAT1 | 1.1 (0.22–62) | 4 (1–66) | 43 (12–176) | |||
| CF | 1.9 (0.06–30) | 7.7 (1–75) | 41 (12–122) | |||
| PF | 2.6 (0.44–62) | 8 (2–81) | 46 (20–127) | |||
| SPH, EIS | 10.5 (1.00–65) | 36 (4–69) | 47 (33–87) | |||
| PPH | 4.5 (0.69–80) | 12.5 (1–105) | 47 (23–147) | |||
| Sarcoidosis | 5.8 (0.40–37) | 19.4 (2–73) | 58 (32–120) | |||
| GVHD | 6.3 (1.00–15) | 11.6 (4–22) | 38 (30–79) | |||
| Bronchiectasis | 2.0 (1.31–9) | 5.8 (3–35) | 41 (31–64) | |||
| Total | 2.0 (0.04–9) | 6.6 (0.5–105) | 43 (12–176) |
| Indications . | Ventilator time (days) . | P-value . | ICU time (days) . | P-value . | Hospital time (days) . | P-value . |
|---|---|---|---|---|---|---|
| LTx type | 0.001 | <0.001 | 0.386 | |||
| SLTx | 1.0 (0.04–62) | 4 (0.5–81) | 42 (12–134) | |||
| DLTx | 2.0 (0.06–95) | 7.6 (1–105) | 42 (12–176) | |||
| HLTx | 7.0 (1.00–22) | 57.3 (24–91) | 67 (33–98) | |||
| Diagnosis | 0.007 | 0.001 | 0.645 | |||
| COPD | 1.0 (0.04–95) | 5.2 (0.5–95) | 44 (12–164) | |||
| AAT1 | 1.1 (0.22–62) | 4 (1–66) | 43 (12–176) | |||
| CF | 1.9 (0.06–30) | 7.7 (1–75) | 41 (12–122) | |||
| PF | 2.6 (0.44–62) | 8 (2–81) | 46 (20–127) | |||
| SPH, EIS | 10.5 (1.00–65) | 36 (4–69) | 47 (33–87) | |||
| PPH | 4.5 (0.69–80) | 12.5 (1–105) | 47 (23–147) | |||
| Sarcoidosis | 5.8 (0.40–37) | 19.4 (2–73) | 58 (32–120) | |||
| GVHD | 6.3 (1.00–15) | 11.6 (4–22) | 38 (30–79) | |||
| Bronchiectasis | 2.0 (1.31–9) | 5.8 (3–35) | 41 (31–64) | |||
| Total | 2.0 (0.04–9) | 6.6 (0.5–105) | 43 (12–176) |
ICU: intensive care unit; COPD: chronic obstructive pulmonary disease; AAT1: α1-antitrypsin deficiency; CF: cystic fibrosis; PF: pulmonary fibrosis; SPH: secondary pulmonary hypertension; EIS: Eisenmenger’s syndrome; PPH: primary pulmonary hypertension; GVHD: graft-vs-host disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
